About Medifast (NYSE:MED)
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
Industry, Sector and Symbol
Industry Miscellaneous food preparations & kindred products
Trailing P/E Ratio73.41
Forward P/E Ratio46.45
Sales & Book Value
Annual Sales$301.56 million
Price / Sales6.78
Cash Flow$2.8383 per share
Price / Cash59.74
Book Value$9.10 per share
Price / Book18.63
EPS (Most Recent Fiscal Year)$2.29
Net Income$27.72 million
Return on Equity31.11%
Return on Assets24.07%
Medifast (NYSE:MED) Frequently Asked Questions
What is Medifast's stock symbol?
Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."
How often does Medifast pay dividends? What is the dividend yield for Medifast?
Medifast declared a quarterly dividend on Friday, June 15th. Shareholders of record on Friday, June 29th will be paid a dividend of $0.48 per share on Wednesday, August 8th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Thursday, June 28th. View Medifast's Dividend History.
How were Medifast's earnings last quarter?
Medifast Inc (NYSE:MED) issued its earnings results on Thursday, May, 3rd. The specialty retailer reported $1.01 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.86 by $0.15. The specialty retailer had revenue of $98.60 million for the quarter, compared to analyst estimates of $89.23 million. Medifast had a net margin of 10.26% and a return on equity of 31.11%. Medifast's quarterly revenue was up 39.7% on a year-over-year basis. During the same period last year, the business earned $0.36 EPS. View Medifast's Earnings History.
When is Medifast's next earnings date?
What guidance has Medifast issued on next quarter's earnings?
Medifast issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share guidance of $3.55-3.65 for the period, compared to the Thomson Reuters consensus estimate of $3.24. The company issued revenue guidance of $385-395 million, compared to the consensus revenue estimate of $354.90 million.Medifast also updated its Q2 guidance to $0.94-0.97 EPS.
What price target have analysts set for MED?
2 brokerages have issued twelve-month price targets for Medifast's stock. Their predictions range from $55.00 to $161.00. On average, they anticipate Medifast's stock price to reach $108.00 in the next year. View Analyst Ratings for Medifast.
Who are some of Medifast's key competitors?
Who are Medifast's key executives?
Medifast's management team includes the folowing people:
- Mr. Daniel R. Chard, CEO & Director (Age 53)
- Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 56)
- Mr. Bill Baker, Exec. VP of Information Technology (Age 46)
- Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)
- Mr. Joseph Kelleman, VP of Fin. & Corp. Controller (Age 63)
Has Medifast been receiving favorable news coverage?
News headlines about MED stock have trended somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Medifast earned a media sentiment score of 0.12 on Accern's scale. They also assigned media stories about the specialty retailer an impact score of 46.38 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.
Who are Medifast's major shareholders?
Medifast's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.40%), Millennium Management LLC (2.40%), American Century Companies Inc. (1.82%), Summit Trail Advisors LLC (1.45%), Northern Trust Corp (1.12%) and Old Mutual Global Investors UK Ltd. (1.09%). Company insiders that own Medifast stock include Charles P Connolly, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.
Which major investors are selling Medifast stock?
MED stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., American Century Companies Inc., HL Financial Services LLC, BNP Paribas Arbitrage SA, Seizert Capital Partners LLC, JPMorgan Chase & Co., Wells Fargo & Company MN and GSA Capital Partners LLP. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Glenn W Welling, Jeremy John Martin, Michael C Macdonald and Ralph Rushton. View Insider Buying and Selling for Medifast.
Which major investors are buying Medifast stock?
MED stock was purchased by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Millennium Management LLC, Prudential Financial Inc., Great Lakes Advisors LLC, Allianz Asset Management GmbH, Allianz Asset Management GmbH, Landscape Capital Management L.L.C. and Old Mutual Global Investors UK Ltd.. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.
How do I buy shares of Medifast?
Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medifast's stock price today?
One share of MED stock can currently be purchased for approximately $169.56.
How big of a company is Medifast?
Medifast has a market capitalization of $1.97 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe.
How can I contact Medifast?
Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]
MarketBeat Community Rating for Medifast (MED)MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.